Nonaminoglycoside compounds induce readthrough of nonsense mutations
Open accessThe DOI matches its Crossref record.
Abstract
Large numbers of genetic disorders are caused by nonsense mutations for which compound-induced readthrough of premature termination codons (PTCs) might be exploited as a potential treatment strategy. We have successfully developed a sensitive and quantitative high-throughput screening (HTS) assay, protein transcription/translation (PTT)–enzyme-linked immunosorbent assay (ELISA), for identifying novel PTC-readthrough compounds using ataxia-telangiectasia (A-T) as a genetic disease model. This HTS PTT-ELISA assay is based on a coupled PTT that uses plasmid templates containing prototypic A-T mutated (ATM) mutations for HTS. The assay is luciferase independent. We screened ∼34,000 compounds and identified 12 low-molecular-mass nonaminoglycosides with potential PTC-readthrough activity. From these, two leading compounds consistently induced functional ATM protein in ATM-deficient cells containing disease-causing nonsense mutations, as demonstrated by direct measurement of ATM protein, restored ATM kinase activity, and colony survival assays for cellular radiosensitivity. The two compounds also demonstrated readthrough activity in mdx mouse myotube cells carrying a nonsense mutation and induced significant amounts of dystrophin protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Nonsense-mediated mRNA decay in humans at a glance
Kurosaki, T., & Maquat, L. E. (2016) · Journal of Cell Science · doi:10.1242/jcs.181008 · Cited by 396
“…with the use of the nonsense-codon suppressors Ataluren, read-through compound (RTC)13, Amlexanox, synthetic aminoglycosides and nonaminoglycosides (Du et al., 2008, 2009; Gonzalez-Hilarion et al., 2012; Nakamura et al., 2012; Shalev and Baasov, 2014; Welch et al., 2007), although their lack of…”
Background4-Thiazolidinones: The advances continue…
Tripathi, A. C., Gupta, S. J., Fatima, G. N., Sonar, P. K., Verma, A., & Saraf, S. K. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.11.017 · Cited by 319
Duchenne and Becker Muscular Dystrophies
Flanigan, K. M. (2014) · Neurologic Clinics · doi:10.1016/j.ncl.2014.05.002 · Cited by 317
Therapeutics Based on Stop Codon Readthrough
Keeling, K. M., Xue, X., Gunn, G., & Bedwell, D. M. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153527 · Cited by 306
ATM is down-regulated by N-Myc–regulated microRNA-421
Hu, H., Du, L., Nagabayashi, G., Seeger, R. C., & Gatti, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907763107 · Cited by 260
Self-citation
Metadata
- Authors
- Du, L., Damoiseaux, R., Nahas, S., Gao, K., Hu, H., Pollard, J. M., Goldstine, J., Jung, M. E., Henning, S. M., Bertoni, C., & Gatti, R. A.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2009-09-21
- Volume
- 206
- Issue
- 10
- Pages
- 2285-2297
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2148743406
- Cited by
- 136
- References
- 0
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonaminoglycoside compounds induce readthrough of nonsense mutations. https://app.cochat.ai/papers/10.1084/jem.20081940
- The paper
- Du, L., Damoiseaux, R., Nahas, S., Gao, K., Hu, H., Pollard, J. M., Goldstine, J., Jung, M. E., Henning, S. M., Bertoni, C., & Gatti, R. A. (2009). Nonaminoglycoside compounds induce readthrough of nonsense mutations. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20081940
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.